RMND5B
Basic information
Region (hg38): 5:178130996-178150568
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Dyskeratosis congenita, autosomal recessive 1 (1 variants)
- Dyskeratosis congenita, autosomal recessive 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RMND5B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 25 | 16 | 43 | |||
Total | 1 | 0 | 49 | 16 | 1 |
Variants in RMND5B
This is a list of pathogenic ClinVar variants found in the RMND5B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-178138207-G-C | not specified | Uncertain significance (Nov 09, 2023) | ||
5-178138219-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
5-178138238-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
5-178142595-C-A | not specified | Uncertain significance (Oct 14, 2023) | ||
5-178142639-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
5-178142640-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
5-178142870-T-C | not specified | Uncertain significance (May 03, 2023) | ||
5-178142874-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
5-178142901-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
5-178142936-A-G | not specified | Uncertain significance (Dec 11, 2023) | ||
5-178142972-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
5-178143664-C-G | not specified | Uncertain significance (Mar 19, 2024) | ||
5-178143949-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
5-178144043-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
5-178146140-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
5-178146195-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
5-178146212-T-C | not specified | Uncertain significance (Nov 13, 2023) | ||
5-178146227-C-T | not specified | Uncertain significance (Nov 12, 2021) | ||
5-178146228-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
5-178147593-G-T | not specified | Uncertain significance (Dec 06, 2022) | ||
5-178147615-A-G | not specified | Uncertain significance (Feb 17, 2024) | ||
5-178147621-A-G | not specified | Uncertain significance (Nov 18, 2022) | ||
5-178147634-C-T | not specified | Uncertain significance (May 25, 2022) | ||
5-178147736-T-C | not specified | Uncertain significance (Mar 15, 2023) | ||
5-178147799-C-T | not specified | Uncertain significance (Apr 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RMND5B | protein_coding | protein_coding | ENST00000515098 | 9 | 19570 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.95e-13 | 0.0595 | 125597 | 1 | 150 | 125748 | 0.000601 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.706 | 212 | 243 | 0.873 | 0.0000151 | 2554 |
Missense in Polyphen | 53 | 67.608 | 0.78393 | 764 | ||
Synonymous | 0.135 | 103 | 105 | 0.983 | 0.00000673 | 779 |
Loss of Function | 0.467 | 21 | 23.4 | 0.896 | 0.00000129 | 240 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000695 | 0.000695 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.00102 | 0.00101 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1. MAEA and RMND5A are both required for catalytic activity of the CTLH E3 ubiquitin-protein ligase complex (PubMed:29911972). Catalytic activity of the complex is required for normal cell proliferation (PubMed:29911972). The CTLH E3 ubiquitin-protein ligase complex is not required for the degradation of enzymes involved in gluconeogenesis, such as FBP1 (PubMed:29911972). {ECO:0000269|PubMed:29911972}.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.329
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.97
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- N
- hipred_score
- 0.389
- ghis
- 0.560
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.858
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rmnd5b
- Phenotype
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process
- Cellular component
- nucleus;cytoplasm;cytosol;GID complex
- Molecular function
- ubiquitin-protein transferase activity;metal ion binding